Glycine From China; Determination, 9223 [2017-02340]

Download as PDF Federal Register / Vol. 82, No. 22 / Friday, February 3, 2017 / Notices By order of the Commission. Issued: January 30, 2017. Lisa R. Barton, Secretary to the Commission. [FR Doc. 2017–02276 Filed 2–2–17; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 731–TA–1306 (Final)] asabaliauskas on DSK3SPTVN1PROD with NOTICES Determination On the basis of the record 1 developed in the subject investigation, the United States International Trade Commission (‘‘Commission’’) determines, pursuant to section 735(b) of the Tariff Act of 1930 (19 U.S.C. 1673d(b)) (‘‘the Act’’), that an industry in the United States is materially injured by reason of imports of large residential washers from China, provided for in subheading 8450.20.00 of the Harmonized Tariff Schedule of the United States, that have been found by the Department of Commerce (‘‘Commerce’’) to be sold in the United States at less than fair value (‘‘LTFV’’). Background The Commission instituted this investigation effective December 16, 2015, following receipt of a petition filed with the Commission and Commerce by Whirlpool Corporation, Benton Harbor, Michigan. The Commission scheduled the final phase of the investigation following notification of a preliminary determination by Commerce that imports of large residential washers from China were being sold at LTFV within the meaning of section 733(b) of the Act (19 U.S.C. 1673b(b)). Notice of the scheduling of the final phase of the Commission’s investigation and of a public hearing to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register of August 18, 2016 (81 FR 55231). The hearing was held in Washington, DC, on December 7, 2016, 1 The record is defined in sec. 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR 207.2(f)). Jkt 241001 Issued: January 31, 2017. Katherine M. Hiner, Acting Supervisory Attorney. On October 3, 2016, the Assistant Administrator, Diversion Control Division, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Richard W. Walker, M.D. (Registrant), of League City, Texas. The Show Cause Order proposed the revocation of his DEA Certificate of Registration No. AW2558750, on the ground that he does not have authority to dispense controlled substances in Texas, the State in which he is registered with the Agency. Order to Show Cause, at 1 (citing 21 U.S.C. 823(f) and 824(a)(3)). With respect to the Agency’s jurisdiction, the Show Cause Order alleged that Registrant is the holder of Registration No. AW2558750, pursuant to which he is authorized to dispense controlled substances in schedules II through V as a practitioner, at the registered address of 4604 Hispania View Drive, League City, Texas. Id. The Order also alleges that Registrant’s registration does not expire until May 31, 2017. Id. As ground for the proposed action, the Show Cause Order alleged that ‘‘[t]he Texas Medical Board issued an order, effective June 10, 2016, which accepted [the] surrender of [his] authority to practice medicine.’’ Id. The Order thus asserted that as a consequence of the Board’s action, Registrant is without authority to dispense controlled substances in Texas, the State in which he is registered, and thus, ‘‘DEA must revoke’’ his Registration. Id. at 1 (citing 21 U.S.C. 802(21), 823(f)(1) and 824(a)(3)). The Show Cause Order notified Registrant of his right to request a hearing on the allegations or to submit a written statement in lieu of a hearing, the procedure for electing either option, and the consequence of failing to elect either option. Id. at 2 (citing 21 CFR 1301.43). The Show Cause Order also notified Registrant of his right to submit a corrective action plan. Id. at 2–3 (citing 21 U.S.C. 824(c)(2)(C)). [FR Doc. 2017–02245 Filed 2–2–17; 8:45 am] Large Residential Washers From China 17:26 Feb 02, 2017 and all persons who requested the opportunity were permitted to appear in person or by counsel. The Commission made this determination pursuant to section 735(b) of the Act (19 U.S.C. 1673d(b)). It completed and filed its determination in this investigation on January 30, 2017. The views of the Commission are contained in USITC Publication 4666 (January 2017), entitled Large Residential Washers from China: Investigation No. 731–TA–1306 (Final). By order of the Commission. Issued: January 30, 2017. Lisa R. Barton, Secretary to the Commission. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). VerDate Sep<11>2014 9223 BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 731–TA–718 (Fourth Review)] Glycine From China; Determination On the basis of the record 1 developed in the subject five-year review, the United States International Trade Commission (‘‘Commission’’) determines, pursuant to the Tariff Act of 1930 (‘‘the Act’’), that revocation of the antidumping duty order on glycine from China would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time. Background The Commission, pursuant to section 751(c) of the Act (19 U.S.C. 1675(c)), instituted this review on August 1, 2016 (81 FR 50547) and determined on November 4, 2016 that it would conduct an expedited review (81 FR 87589, December 5, 2016). The Commission made this determination pursuant to section 751(c) of the Act (19 U.S.C. 1675(c)). It completed and filed its determination in this review on January 31, 2017. The views of the Commission are contained in USITC Publication 4667 (January 2017), entitled Glycine From China: Investigation No. 731–TA–718 (Fourth Review). By order of the Commission. 1 The record is defined in sec. 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR 207.2(f)). PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 [FR Doc. 2017–02340 Filed 2–2–17; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Richard W. Walker, Jr., M.D.; Decision and Order E:\FR\FM\03FEN1.SGM 03FEN1

Agencies

[Federal Register Volume 82, Number 22 (Friday, February 3, 2017)]
[Notices]
[Page 9223]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02340]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-718 (Fourth Review)]


Glycine From China; Determination

    On the basis of the record \1\ developed in the subject five-year 
review, the United States International Trade Commission 
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the 
Act''), that revocation of the antidumping duty order on glycine from 
China would be likely to lead to continuation or recurrence of material 
injury to an industry in the United States within a reasonably 
foreseeable time.
---------------------------------------------------------------------------

    \1\ The record is defined in sec. 207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------

Background

    The Commission, pursuant to section 751(c) of the Act (19 U.S.C. 
1675(c)), instituted this review on August 1, 2016 (81 FR 50547) and 
determined on November 4, 2016 that it would conduct an expedited 
review (81 FR 87589, December 5, 2016).
    The Commission made this determination pursuant to section 751(c) 
of the Act (19 U.S.C. 1675(c)). It completed and filed its 
determination in this review on January 31, 2017. The views of the 
Commission are contained in USITC Publication 4667 (January 2017), 
entitled Glycine From China: Investigation No. 731-TA-718 (Fourth 
Review).

    By order of the Commission.

    Issued: January 31, 2017.
Katherine M. Hiner,
Acting Supervisory Attorney.
[FR Doc. 2017-02340 Filed 2-2-17; 8:45 am]
 BILLING CODE 7020-02-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.